The FDA has scolded Pfizer over Facebook ads for the cancer drug Adcetris, accusing the Big Pharma of failing to adequately communicate the indication, contraindications and risks. Continuing a wave ...
Regulators claim Pfizer’s ads created a misleading impression by describing Adcetris as a treatment for broader T-cell lymphoma populations than those covered by its FDA-approved label. The FDA also ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results